Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study evaluates RMC-035 compared to placebo for the prevention of acute kidney injury (AKI) in subjects who are at high risk for AKI following cardiac surgery. Half of the subjects will receive RMC-035 and the other half will receive placebo.
Epistemonikos ID: aee447489c603aff8110fe9150235b8d46c6d020
First added on: May 09, 2024